MHRA authorises in vivo genome editing trial

1st March 2018 Uncategorised 0

The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted permission for initiation of Europe’s first in vivo genome editing study.

More: MHRA authorises in vivo genome editing trial
Source: News